Table 1.
Clinical characteristics of participants and classification based on self-reported physical activity.
| Characteristic1 | Mean ± SD or N (%) |
|---|---|
| Age at diagnosis, y | 61 ± 8 |
| Body mass index, kg/m2 | 26 ± 5 |
| Race | |
| Caucasian | 55 (77) |
| African American | 3 (4) |
| Asian | 2 (3) |
| Not reported | 11 (15) |
| Prostate specific antigen | 4.4 ± 2.3 |
| Gleason sum | |
| 3 | 1 (4) |
| 5 | 1 (4) |
| 6 | 23 (82) |
| 7 | 3 (11) |
| Clinical T-stage | |
| T1c | 55 (77) |
| T2a | 16 (23) |
|
| |
| Physical activity classification | |
|
| |
| ≥3 h/wk vigorous activity2 | 16 (23) |
| Any vigorous activity2 | 33 (46) |
| Met US Physical Activity Guidelines for Older Adults3 | 35 (49) |
| Overweight or obese4 | 38 (57) |
Clinical characteristics and physical activity are from the baseline assessment of the MENS trial. The baseline biopsy and clinical data were collected a median of 3 months after diagnosis and the physical activity data were collected a median of 2 months after the baseline clinical visit.
A man was classified as engaging in vigorous activity if he reported engaging in any activities that require 6+ METS.
A man was classified as meeting the US Physical Activity Guidelines for Older Adults if he reported engaging in 150 min/wk of moderate-intensity, or 75 min/wk of vigorous-intensity aerobic activity, or some combination thereof.
A man was classified as overweight/obese if he had a body mass index (BMI) ≥25 kg/m2. Eight men of these men had BMI ≥30 kg/m2. BMI data was missing for 4 men.